Where does Clexio Biosciences Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Clexio Biosciences Ltd. ranks #9,470 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Clexio Biosciences Ltd. hold?

Clexio Biosciences Ltd. holds 33 US utility patents granted between 2019 and 2025, spanning 11 technology areas.

What is Clexio Biosciences Ltd.'s Innovation Score?

Clexio Biosciences Ltd. has an Innovation Score of 47.6 out of 100 (top 18% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Clexio Biosciences Ltd. focus on?

Clexio Biosciences Ltd.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 33 patents, ranking #676 of 7,163 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

Is Clexio Biosciences Ltd.'s patent grant rate increasing or decreasing?

Clexio Biosciences Ltd.'s recent grant velocity is +733% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Clexio Biosciences Ltd.'s patents?

Clexio Biosciences Ltd.'s patents average 19.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Clexio Biosciences Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Clexio Biosciences Ltd.

USPTO PatentsView assignee record - 33 granted patents across 11 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Clexio ranks #9,470 of 49,997 tracked US assignees by granted-patent volume, with 33 patents across 11 technology areas.

#9,470
of 49,997 US assignees by volume: Top 18%
by Innovation Score (47.6/100): 19.5
avg claims per patent: +733%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9470 · Foreign Corporation #9,470 · 33 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 33 grants
UPPER-Q #9,470/49,997
PHOTO-FINISH Calera
CPC-FOCUS A61K · 11 areas
INNOV-PAR 47.6/100
CLAIMS-RICH 19.5 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +733% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Calera Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Clexio’s 47.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.2 pts (26%) Velocity 12.0 pts (25%) Breadth 11.7 pts (25%) Claim depth 11.7 pts (25%)

Qualcomm Incorporated · highest

85
Clexio Biosciences · this assignee

48
Magnecomp · near

48
National University… · near

48
Otsuka Chemical · near

48
Werner · near

48
3D Lighting… · lowest

7

What this shows Clexio's Innovation Score is 47.6/100 (top 18% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Clexio?

Each dot is one of Clexio’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Clexio’s own 19.5 claims/patent is ABOVE the 15.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Clexio vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Clexio's grants concentrate

Clexio Biosciences Ltd. is a focused PatentsView assignee: 11 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2024 (8 grants) versus a trough of 2 in 2020. By volume, Clexio sits between Capitalbio Corporation and Clover Technologies Group, LLC.

Clexio's three-year grant acceleration

Clexio Biosciences Ltd. shows 18 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Capitalbio

33
Carl Zeiss X-ray…

33
Cell Signaling Te…

33
Center FOR Advanc…

33
Crimson Consulting

33
Crrc Qingdao Sifa…

33
Calera

33
Clover Group

33
Clexio Biosciences ◀

33

What this shows Clexio holds 33 patents at rank #9,469, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Clexio

By rank, the assignees closest to #9,469 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Clexio's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Clexio, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Clexio ranks #676 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (48 here).

National University Corporation Saitama University 48 Otsuka Chemical Co., Ltd. 48 Magnecomp Corporation 48 Werner Co. 48

Clexio's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

48 Top 18% higher than 82% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Clexio Biosciences Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	3	9.1%
2020	2	6.1%
2021	5	15.2%
2022	5	15.2%
2023	5	15.2%
2024	8	24.2%
2025partial year	5	15.2%

Which technologies does Clexio Biosciences Ltd. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 33

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 22

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 8

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 3

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 3

A61B - DIAGNOSIS; SURGERY; Identification 2

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 1

B29K - Indexing Scheme Associated With Subclasses B29b, B29c OR B29d, Relating TO Moulding Materials OR TO Materials FOR ; Moulds, ; Reinforcements, Fillers OR Preformed Parts, e.g. Inserts 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 1

D06M - Treatment, NOT Provided FOR Elsewhere IN Class D06, OF Fibres, Threads, Yarns, Fabrics, Feathers OR Fibrous Goods Made From Such Materials 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Clexio Biosciences Ltd.'s patent record in context - here's where to go next.

Clexio Biosciences Ltd.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #9,470 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Clexio Biosciences Ltd. against Capitalbio Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 47.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.